Column Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Column Capital Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200	Closed	-$1.1K	–	812
2023 Q2	$1.1K	Hold	200	–	–	﹤0.01%	746
2023 Q1	$1.25K	Hold	200	–	–	﹤0.01%	756
2022 Q4	$932	Hold	200	–	–	﹤0.01%	762
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	680
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	682
2022 Q1	$4K	Buy	+200	New	+$4.59K	﹤0.01%	591

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SQN Investors Menlo Park, California $12.8M AUM

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Column Capital Advisors's GDRX Position: Q3 2023 in Review

Column Capital Advisors sold out of GoodRx Holdings (GDRX) in Q3 2023, closing a stake of 200 shares — an estimated $1.1K sold.

Column Capital Advisors first reported a position in GDRX in Q1 2022 and held it in 6 quarters. The position peaked at $4K in Q1 2022. 155 funds tracked by Wall St. Rank hold GDRX as of Q3 2023.

Column Capital Advisors reported no remaining GoodRx Holdings position as of Q3 2023 after selling out during the quarter.
Column Capital Advisors sold 200 GoodRx Holdings shares in Q3 2023, an estimated $1.1K.
Column Capital Advisors first reported a position in GoodRx Holdings in Q1 2022 and held it in 6 quarters.
Column Capital Advisors's GoodRx Holdings position peaked at $4K in Q1 2022.
155 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.